Capital Expenditures for Illumina (ILMN)
According to Illumina's latest reported financial statements, the company's current capital expenditures (TTM) is $140.00M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
ILMN
Currently viewingCapital ExpendituresSwitch metric
Latest period
$140.00M
YoY change
+15.6%
5Y CAGR
-4.8%
Peak year (2017)
$312.00M
Cumulative capital expenditures
$3.09B
CapEx history chart for Illumina (ILMN) from 1999 to 2025
CapEx history table for Illumina (ILMN) from 1999 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $148.00M | +15.6% | ||
| 2024 | $128.00M | -34.4% | ||
| 2023 | $195.00M | -31.8% | ||
| 2022 | $286.00M | +37.5% | ||
| 2021 | $208.00M | +10.1% | ||
| 2020 | $189.00M | -9.6% | ||
| 2019 | $209.00M | -29.4% | ||
| 2018 | $296.00M | -5.1% | ||
| 2017 | $312.00M | +15.0% | ||
| 2016 | $271.38M | +89.4% | ||
| 2015 | $143.25M | +0.7% | ||
| 2014 | $142.22M | +57.0% | ||
| 2013 | $90.56M | +11.8% | ||
| 2012 | $81.01M | +1.8% | ||
| 2011 | $79.55M | +40.9% | ||
| 2010 | $56.47M | +2.3% | ||
| 2009 | $55.22M | -42.3% | ||
| 2008 | $95.69M | +291.7% | ||
| 2007 | $24.43M | +60.6% | ||
| 2006 | $15.21M | +33.5% | ||
| 2005 | $11.39M | +239.6% | ||
| 2004 | $3.35M | +65.1% | ||
| 2003 | $2.03M | -92.4% | ||
| 2002 | $26.83M | +79.2% | ||
| 2001 | $14.97M | +336.7% | ||
| 2000 | $3.43M | +1060.9% | ||
| 1999 | $295,286 | — |
CapEx values are taken from Illumina's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual capital expenditures for Illumina (ILMN) came in at $148.00M – grew 15.6% year-over-year.
Illumina capital expenditures has contracted on net over the period, with a -4.8% compound annual growth rate over 2020–2025 (5 years).
Illumina capital expenditures peaked at $312.00M in 2017; the latest annual figure is $148.00M in 2025 (52.6% below peak).
The highest annual capital expenditures of $312.00M was reported in 2017. The lowest in the available history was $295,286 in 1999.
Illumina (ILMN) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.
Illumina Capital Expenditures by Year
Illumina Capital Expenditures 2025: $148.00M
Illumina capital expenditures in 2025 was $148.00M, grew 15.6% from 2024.
Illumina Capital Expenditures 2024: $128.00M
Illumina capital expenditures in 2024 was $128.00M, plunged 34.4% below 2023.
Illumina Capital Expenditures 2023: $195.00M
Illumina capital expenditures in 2023 was $195.00M, plunged 31.8% below 2022.
Illumina Capital Expenditures 2022: $286.00M
Illumina capital expenditures in 2022 was $286.00M, surged 37.5% from 2021.
Illumina Capital Expenditures 2021: $208.00M
Illumina capital expenditures in 2021 was $208.00M.
See more financial history for Illumina (ILMN).
Sector peers — CapEx
Companies in the same sector as Illumina, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Illumina's capital expenditures?
- Latest reported capital expenditures for Illumina (ILMN) is $140.00M (period ending December 28, 2025).
How has Illumina capital expenditures changed year-over-year?
- Illumina (ILMN) capital expenditures changed +15.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Illumina capital expenditures?
- Illumina (ILMN) capital expenditures compound annual growth rate is -4.8% over the most recent 5 years available.
When did Illumina capital expenditures hit its highest annual value?
- Illumina capital expenditures reached its highest annual value of $312.00M in 2017.
What was Illumina capital expenditures in 2024?
- Illumina (ILMN) capital expenditures in 2024 was $128.00M.
What was Illumina capital expenditures in 2025?
- Illumina (ILMN) capital expenditures in 2025 was $148.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ILMN Overview
Company profile, financial tools, and key metrics
ILMN Revenue Counter
Earns $137.68 every second. See per minute, hour, and day.
ILMN Earnings Counter
Earns $26.95 per second net profit. See per minute, hour, and day.
ILMN Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
ILMN What If Invested
What if you had invested $1,000? See historical returns from any date.
ILMN How It Makes Money
Discover visual breakdown of $4.34B in revenue — where it comes from and where it goes.
ILMN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ILMN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ILMN Daily Price Character
Explosive · 50.0% historical win rate (green days). Streaks & record days.
ILMN Buybacks
3.61% TTM buyback yield. Shareholder yield & SBC comparison.
ILMN Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.